特纳综合征妊娠的产科特征与结局评估
基于美国全国住院样本2016-2020年17,865,495例住院分娩的横断面研究,特纳综合征妊娠患病率为每10万例分娩7.0例,其发生宫内胎死、围存活期分娩等风险显著升高,作者认为应建立学会层面的孕前咨询与产前随访方法。
要点
- 特纳综合征妊娠患病率为每10万例分娩7.0例,研究期间从5.0升至11.7。
- 特纳综合征妊娠的宫内胎死风险升高(aOR 8.40)。
- 特纳综合征妊娠的围存活期分娩风险升高(22-25周aOR 5.88)。
核心结论
- 美国同期全国性评估结果表明,特纳综合征妊娠虽不常见,但可能代表高危人群,尤其宫内胎死和围存活期分娩风险升高。
- 作者认为建立学会层面的孕前咨询与产前随访方法在临床上有说服力。
研究设计与样本
- 横断面研究,数据来自医疗成本与利用项目全国住院样本。
- 共纳入2016-2020年17,865,495例住院分娩。
- 暴露定义为根据世界卫生组织国际疾病分类第10版编码Q96识别的特纳综合征诊断。
- 采用逆概率治疗加权队列和多变量二元逻辑回归模型评估产科结局。
主要发现
- 特纳综合征妊娠患病率为每10万例分娩7.0例(即1/14,235)。
- 研究期间特纳综合征诊断的住院分娩数从每10万例分娩5.0例增至11.7例(2020年 vs 2016年 aOR 2.18,95%CI 1.83-2.60)。
- 特纳综合征妊娠较无特纳综合征者更常诊断孕前高血压(4.8% vs 2.8%;aOR 1.65;95%CI 1.26-2.15)、子宫畸形(1.6% vs 0.4%;aOR 3.01;95%CI 1.93-4.69)和既往妊娠丢失(1.6% vs 0.3%;aOR 4.70;95%CI 3.01-7.32)。
- 特纳综合征与宫内胎死风险升高相关(10.9% vs 0.7%;aOR 8.40;95%CI 5.30-13.30)、宫内生长受限风险升高相关(8.5% vs 3.5%;aOR 2.11;95%CI 1.48-2.99)和胎盘植入谱系风险升高相关(aOR 3.63;95%CI 1.20-10.97)。
- 特纳综合征妊娠更常行剖宫产(41.6% vs 32.3%;aOR 1.53;95%CI 1.26-1.87),且围存活期分娩(22-25周:6.1% vs 0.4%;aOR 5.88;95%CI 3.47-9.98)和存活前期分娩(<22周:3.3% vs 0.3%;aOR 2.87;95%CI 1.45-5.69)的比值比较无特纳综合征者升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess national-level trends, characteristics, and outcomes of pregnancies with Turner syndrome in the United States. DESIGN: Cross-sectional study. SETTING: The Healthcare Cost and Utilization Project's National Inpatient Sample. SUBJECTS: A total of 17,865,495 hospital deliveries from 2016-2020. EXPOSURE: A diagnosis of Turner syndrome, identified according to the World Health Organization's International Classification of Disease 10th revision code of Q96. MAIN OUTCOME MEASURES: Obstetrics outcomes related to Turner syndrome, assessed with inverse probability of treatment weighting cohort and multivariable binary logistic regression modeling. RESULTS: The prevalence of pregnant patients with Turner syndrome was 7.0 per 100,000 deliveries (one in 14,235). The number of hospital deliveries with patients who have a diagnosis of Turner syndrome increased from 5.0 to 11.7 per 100,000 deliveries during the study period (adjusted-odds ratio [aOR] for 2020 vs. 2016; 2.18, 95% confidence interval [CI] 1.83-2.60). Pregnant patients with Turner syndrome were more likely to have a diagnosis of pregestational hypertension (4.8% vs. 2.8%; aOR 1.65; 95% CI 1.26-2.15), uterine anomaly (1.6% vs. 0.4%; aOR, 3.01; 95% CI 1.93-4.69), and prior pregnancy losses (1.6% vs. 0.3%; aOR 4.70; 95% CI 3.01-7.32) compared with those without Turner syndrome. For the index obstetric characteristics, Turner syndrome was associated with an increased risk of intrauterine fetal demise (10.9% vs. 0.7%; aOR 8.40; 95% CI 5.30-13.30), intrauterine growth restriction (8.5% vs. 3.5%; aOR 2.11; 95% CI 1.48-2.99), and placenta accreta spectrum (aOR 3.63; 95% CI 1.20-10.97). For delivery outcome, pregnant patients with Turner syndrome were more likely to undergo cesarean delivery (41.6% vs. 32.3%; aOR 1.53; 95% CI 1.26-1.87). Moreover, the odds of periviable delivery (22-25 weeks: 6.1% vs. 0.4%; aOR 5.88; 95% CI 3.47-9.98) and previable delivery (<22 weeks: 3.3% vs. 0.3%; aOR 2.87; 95% CI 1.45-5.69) were increased compared with those without Turner syndrome. CONCLUSIONS: The results of contemporaneous, nationwide assessment in the United States suggest that although pregnancy with Turner syndrome is uncommon this may represent a high-risk group, particularly for intrauterine fetal demise and periviable delivery. Establishing a society-based approach for preconception counseling and antenatal follow-up would be clinically compelling.
引用
- Anderson ZS, Masjedi AD, Aberle LS, et al. Assessment of obstetric characteristics and outcomes associated with pregnancy with Turner syndrome. Fertil Steril. 2024. PMID: 38522502. doi:10.1016/j.fertnstert.2024.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。